CHeBA Co-Director, Professor Henry Brodaty, along with an international research, has been awarded $400,000 to strengthen professional collaboration in dementia caregiver education and research.
A six-year study of older Australians in CHeBA’s Sydney Memory and Ageing Study has uncovered an Australian-first association between the impact of hearing loss on cognitive abilities and increased risk for dementia.
Evidence suggest people with dementia are more likely to contract COVID-19 and to have severe disease outcomes from the virus, including increased risk of death.
The evidence for the harmful effects of alcohol on brain health is compelling, but now experts have pin-pointed three key time periods in life when the effects of alcohol are likely to be at their greatest.
A six-year study of older Australians with type 2 diabetes has uncovered a link between metformin use, slower cognitive decline and lower dementia rates.
The proportion of people with dementia in rural and regional Australia is consistent with that of metropolitan areas. Access to diagnosis and support however is not.
In a world first, Australian researchers have discovered a new mechanism in the brain that has the potential to reduce the impact of debilitating neuroinflammatory diseases.
New findings from a collaboration of researchers from NeuRA, UNSW Sydney’s Centre for Healthy Brain Ageing (CHeBA) and the University of Sydney shed light on Alzheimer's disease treatments.
An international research study led by the Centre for Healthy Brain Ageing (CHeBA) provides further support to the finding that more education is associated with a decreased risk of dementia.
CHeBA is proud to present Professor John O’Brien of the University of Cambridge for his talk: Improving the Diagnosis and Management of Lewy Body Dementia.
